Edoardo Marrani Selected Research

1-(2-chloroethyl)-1-nitrosourea (CNU)

12/2021

A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edoardo Marrani Research Topics

Disease

5	Uveitis 01/2022 - 10/2015
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2022 - 10/2013
3	Vasculitis (Vasculitides) 11/2022 - 12/2021
2	Infections 09/2022 - 05/2021
2	Communicable Diseases (Infectious Diseases) 09/2022 - 01/2022
2	Rheumatic Diseases (Rheumatism) 09/2022 - 01/2019
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021 - 01/2020
2	Fever (Fevers) 01/2021 - 10/2013
2	Inflammation (Inflammations) 01/2021 - 01/2020
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 11/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 09/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Drug Hypersensitivity (Drug Allergy) 01/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Disease Progression 12/2021
1	Retinal Vasculitis 11/2021
1	Conjunctivitis 11/2021
1	Optic Neuritis (Retrobulbar Neuritis) 11/2021
1	Retinitis 11/2021
1	Papilledema 11/2021
1	COVID-19 05/2021
1	Hypertrophic Gastritis (Giant Hypertrophic Gastritis) 03/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Familial Mediterranean Fever (Periodic Disease) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Arteritis 01/2021
1	Immediate Hypersensitivity 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Adult-Onset Still's Disease 11/2020
1	Sarcoidosis (Schaumann Disease) 03/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Exanthema (Rash) 01/2019
1	Acute Generalized Exanthematous Pustulosis 01/2019
1	Localized Scleroderma (Morphea) 12/2018
1	Limited Scleroderma 12/2018
1	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 11/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2018
1	Osteoporosis 04/2017
1	Hypoalbuminemia 01/2017
1	Cardiovascular Abnormalities 01/2017
1	Hyponatremia 01/2017
1	Pericarditis 10/2013
1	Macrophage Activation Syndrome 10/2013
1	Arthritis (Polyarthritis) 10/2013
1	Anemia 10/2013

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 11/2022 - 01/2019
5	Biological ProductsIBA 02/2022 - 10/2013
3	Infliximab (Remicade)FDA Link 11/2022 - 11/2018
3	Adalimumab (Humira)FDA Link 02/2022 - 12/2021
2	Immunoglobulin A (IgA)IBA 11/2022 - 12/2021
2	tocilizumab (atlizumab)FDA Link 02/2022 - 01/2022
2	Rituximab (Mabthera)FDA Link 02/2022 - 01/2021
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 12/2018
2	Abatacept (Orencia)FDA Link 01/2022 - 10/2015
2	Interleukin-1 (Interleukin 1)IBA 01/2021 - 01/2020
2	SteroidsIBA 01/2021 - 01/2021
1	Biosimilar PharmaceuticalsIBA 11/2022
1	Immunoglobulins (Immunoglobulin)IBA 09/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2022
1	Immunoglobulin G (IgG)IBA 09/2022
1	Etanercept (Enbrel)FDA Link 02/2022
1	Carbon MonoxideIBA 01/2022
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	1-(2-chloroethyl)-1-nitrosourea (CNU)IBA 12/2021
1	AntibodiesIBA 12/2021
1	Peptides (Polypeptides)IBA 12/2021
1	veltuzumabIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 03/2021
1	Tryptases (Tryptase)IBA 01/2021
1	Colchicine FDA LinkGeneric 01/2021
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	amsonic acid (DAS)IBA 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2020
1	CytokinesIBA 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019
1	Ficusin (Psoralen)IBA 12/2018
1	Anabolic AgentsIBA 04/2017
1	Diphosphonates (Bisphosphonates)IBA 04/2017
1	C-Reactive ProteinIBA 01/2017
1	TroponinIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	triamcinolone hexacetonide (Aristospan)FDA Link 10/2013
1	GlucocorticoidsIBA 10/2013

Therapy/Procedure

7	Therapeutics 09/2022 - 10/2015
1	Biological Therapy 02/2022
1	Precision Medicine 02/2022
1	Phototherapy (Light Therapy) 12/2018
1	Drug Therapy (Chemotherapy) 10/2013